(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 16.63% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.58%.
Astrana Health's revenue in 2025 is $2,896,455,000.On average, 12 Wall Street analysts forecast ASTH's revenue for 2025 to be $181,361,273,130, with the lowest ASTH revenue forecast at $172,918,010,880, and the highest ASTH revenue forecast at $187,384,133,535. On average, 12 Wall Street analysts forecast ASTH's revenue for 2026 to be $227,574,061,845, with the lowest ASTH revenue forecast at $196,671,722,010, and the highest ASTH revenue forecast at $248,119,333,320.
In 2027, ASTH is forecast to generate $254,142,193,725 in revenue, with the lowest revenue forecast at $214,402,572,735 and the highest revenue forecast at $284,875,668,315.